Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common <i>Candida</i> Species: A Propensity Score Matching Analysis

Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common <i>Candida</i> Species: A Propensity Score Matching Analysis

This study aimed to evaluate the effectiveness of fluconazole and echinocandins in the treatment of candidemia caused by both fluconazole- and echinocandin-susceptible common <i>Candida</i> species. A retrospective study which enrolled adult candidemia patients ≥19 years diagnosed at a t...

Full description

Bibliographic Details
Main Authors:	Jong Hun Kim, Jin Woong Suh, Min Ja Kim
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Journal of Fungi
Subjects:	candidemia fluconazole echinocandin mortality
Online Access:	https://www.mdpi.com/2309-608X/9/5/539

Similar Items

Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU
by: Farnaz Daneshnia, et al.
Published: (2022-12-01)

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
by: Gebremedhin Beedemariam Gebretekle, et al.
Published: (2022-10-01)

Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
by: Yating Ning, et al.
Published: (2023-12-01)

Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance
by: Marine Grosset, et al.
Published: (2016-12-01)

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
by: Huang-Tz Ou, et al.
Published: (2017-07-01)

Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil
by: Valério Rodrigues Aquino, et al.

The Emergence of Echinocandin-Resistant <i>Candida glabrata</i> Exhibiting High MICs and Related <i>FKS</i> Mutations in Turkey
by: Ali Korhan Sig, et al.
Published: (2021-08-01)

Evaluation of the early fluconazole treatment of candidemia protocol with automated short message service alerts: a before-and-after study
by: Jeong Rae Yoo, et al.
Published: (2021-05-01)

Candida species distribution and fluconazole susceptibility of blood isolates at a regional hospital in Passo Fundo, RS, Brazil
by: Maira Giseli C. Silva, et al.
Published: (2015-06-01)

Results of treatment for candidemia in patients with blood system tumors
by: G A Kliasova, et al.
Published: (2013-11-01)

The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates
by: Débora Alves Nunes Mario, et al.
Published: (2012-05-01)

Determinants of fluconazole resistance and the efficacy of fluconazole and milbemycin oxim combination against Candida parapsilosis clinical isolates from Brazil and Turkey
by: Farnaz Daneshnia, et al.
Published: (2022-07-01)

COVID-19-associated candidiasis and the emerging concern of Candida auris infections
by: Chin-Shiang Tsai, et al.
Published: (2023-08-01)

Impact of the COVID-19 Pandemic on the Clinical Profile of Candidemia and the Incidence of Fungemia Due to Fluconazole-Resistant <i>Candida parapsilosis</i>
by: Antonio Ramos-Martínez, et al.
Published: (2022-04-01)

Factors influencing recovery in patients with hemoblastoses and candidemia
by: G A Klyasova, et al.
Published: (2015-07-01)

Treatment of Invasive Candidiasis: A Narrative Review
by: Ronen Ben-Ami
Published: (2018-08-01)

Fatal Breakthrough Candidemia in an Immunocompromised Patient in Kuwait Due to <i>Candida auris</i> Exhibiting Reduced Susceptibility to Echinocandins and Carrying a Novel Mutation in Hotspot-1 of <i>FKS1</i>
by: Inaam Al-Obaid, et al.
Published: (2022-03-01)

Susceptibility to Fluconazole and Voriconazole in Candida Strains Isolated from Blood Culture by Disk Diffusion Method. Maracaibo, Venezuela
by: Armindo Perozo, et al.
Published: (2011-02-01)

Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant <i>Candida tropicalis</i>: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies
by: Maroun M. Sfeir, et al.
Published: (2020-01-01)

Echinocandins versus Amphotericin B Against Candida tropicalis Fungemia in Adult Hematological Patients with Neutropenia: A Multicenter Retrospective Cohort Study
by: You L, et al.
Published: (2020-07-01)

The Second Case of Candida auris Candidemia from Turkey: An Impending Threat to the Global Health
by: Leyla TEKE, et al.
Published: (2021-12-01)

Prescribing patterns of echinocandins in adult patients in a private hospital in Gauteng, South Africa
by: Anja Grey, et al.
Published: (2023-03-01)

A case of Candida famata sepsis in a very low birth weight infant successfully treated with fluconazole following antifungal susceptibility testing
by: Shilpee Raturi, et al.
Published: (2015-01-01)

Impact of the Disk Diffusion Test on Fluconazole De-Escalation in Patients with Candidemia
by: Suchavadee Tantasuwan, et al.
Published: (2022-11-01)

In vitro synergy of echinocandins with triazoles against fluconazole-resistant Candida parapsilosis complex isolates
by: Ali Ahmadi, et al.
Published: (2020-06-01)

A 14-Year Cohort of Candidemia in the Pediatric Population in a Tertiary Center in Jerusalem: Clinical Characteristics, Antifungal Susceptibility, and Risk Factors for Mortality
by: Maya Korem, et al.
Published: (2023-12-01)

Clinical and epidemiological aspects of Candidemia in eight medical centers in the state of Parana, Brazil: Parana Candidemia Network
by: Carla Sakuma de Oliveira, et al.
Published: (2021-01-01)

Necrotizing pancreatitis with invasive candidiasis and candidemia due to Candida albicans and pan-echinocandin-resistant Candida glabrata
by: Laman Rahimli, et al.
Published: (2024-03-01)

In Vitro Characterization of Twenty-One Antifungal Combinations against Echinocandin-Resistant and -Susceptible <i>Candida glabrata</i>
by: Hazim O. Khalifa, et al.
Published: (2021-02-01)

Epidemiology of Candidemia in Children over 7 Years in a Medical Center in Turkey
by: Dilek Yılmaz-Ciftdoğan, et al.
Published: (2021-10-01)

COVID-19 pandemic and the evolving epidemiology of Candidemia: A topic of concern!!!
by: Ekadashi Rajni, et al.
Published: (2022-09-01)

Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment
by: Lausch KR, et al.
Published: (2018-11-01)

Antifungal susceptibility profile of Candida clinical isolates from 22 hospitals of São Paulo State, Brazil
by: D.K.B. Rodrigues, et al.
Published: (2021-06-01)

Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea
by: Yong Jun Choi, et al.
Published: (2018-09-01)

Epidemiological Trends of Candidemia and the Impact of Adherence to the Candidemia Guideline: Six-Year Single-Center Experience
by: Jong Hun Kim, et al.
Published: (2021-04-01)

Candida auris candidemia an emerging threat: A case report and mini review of the literature
by: K Sandhya Bhat, et al.
Published: (2019-01-01)

Some issues of the resistance of Candida glabrata to echinocandins
by: Veselov A.V.
Published: (2019-12-01)

Micafungin Is an Efficient Treatment of Multi Drug-Resistant <i>Candida glabrata</i> Urosepsis: A Case Report
by: Zuzana Javorova Rihova, et al.
Published: (2021-09-01)

<i>Candida albicans</i> Genes Modulating Echinocandin Susceptibility of Caspofungin-Adapted Mutants Are Constitutively Expressed in Clinical Isolates with Intermediate or Full Resistance to Echinocandins
by: Anshuman Yadav, et al.
Published: (2024-03-01)

Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil
by: Adriana Araujo de Almeida, et al.
Published: (2013-06-01)